share_log

19,928 Shares in Semler Scientific, Inc. (OTCMKTS:SMLR) Acquired by Walleye Capital LLC

19,928 Shares in Semler Scientific, Inc. (OTCMKTS:SMLR) Acquired by Walleye Capital LLC

Walleye Capital LLC收购Semler Science,Inc.(场外交易代码:SMLR)的19,928股股份
Defense World ·  2022/09/20 04:11

Walleye Capital LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 19,928 shares of the medical equipment provider's stock, valued at approximately $988,000.

根据Walleye Capital LLC最近提交给美国证券交易委员会(Securities And Exchange Commission)的文件,该公司在第一季度购买了Semler Science,Inc.(场外交易市场代码:SMLR-GET Rating)的新股票头寸。该公司购买了这家医疗设备供应商的19,928股股票,价值约为98.8万美元。

Several other hedge funds have also added to or reduced their stakes in the business. Nantahala Capital Management LLC boosted its position in Semler Scientific by 27.9% during the 1st quarter. Nantahala Capital Management LLC now owns 356,875 shares of the medical equipment provider's stock worth $17,687,000 after buying an additional 77,790 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Semler Scientific by 49.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 227,529 shares of the medical equipment provider's stock worth $11,276,000 after purchasing an additional 75,574 shares during the period. EVR Research LP acquired a new position in shares of Semler Scientific in the 1st quarter worth approximately $9,912,000. Avalon Investment & Advisory lifted its position in shares of Semler Scientific by 244.0% in the 1st quarter. Avalon Investment & Advisory now owns 157,534 shares of the medical equipment provider's stock worth $7,807,000 after purchasing an additional 111,743 shares during the period. Finally, Wasatch Advisors Inc. acquired a new position in shares of Semler Scientific in the 4th quarter worth approximately $10,898,000. 37.99% of the stock is currently owned by institutional investors and hedge funds.

其他几家对冲基金也增持或减持了该业务的股份。第一季度,Nantahala Capital Management LLC将其在Semler Science的头寸增加了27.9%。Nantahala Capital Management LLC现在拥有这家医疗设备提供商356,875股票,价值17,687,000美元,在此期间又购买了77,790股票。高盛股份有限公司在第一季度将其在赛姆勒科学公司的股票头寸提高了49.7%。高盛股份有限公司在此期间又购买了75,574股,目前持有227,529股这家医疗设备供应商的股票,价值11,276,000美元。EVR Research LP在第一季度收购了Semler Science价值约991.2万美元的新股票头寸。阿瓦隆投资咨询公司在第一季度将其在赛姆勒科学公司的股票头寸提高了244.0%。在此期间,Avalon Investment&Consulting又购买了111,743股,现在拥有157,534股这家医疗设备提供商的股票,价值7,807,000美元。最后,Wasatch Advisors Inc.在第四季度收购了Semler Science价值约10,898,000美元的新股票头寸。37.99%的股票目前由机构投资者和对冲基金持有。

Get
到达
Semler Scientific
塞姆勒科学
alerts:
警报:

Semler Scientific Stock Performance

赛姆勒科学股票表现

Shares of OTCMKTS SMLR opened at $39.69 on Tuesday. The company has a market capitalization of $269.93 million, a P/E ratio of 24.65 and a beta of 0.72. Semler Scientific, Inc. has a 52-week low of $27.02 and a 52-week high of $153.21. The company's 50 day moving average price is $38.93 and its 200-day moving average price is $38.35.

周二,OTCMKTS SMLR的股价开盘报39.69美元。该公司市值为2.6993亿美元,市盈率为24.65倍,贝塔系数为0.72。Semler Science,Inc.的52周低点为27.02美元,52周高位为153.21美元。该公司的50日移动均线价格为38.93美元,200日移动均线价格为38.35美元。

Semler Scientific (OTCMKTS:SMLR – Get Rating) last issued its quarterly earnings results on Tuesday, August 2nd. The medical equipment provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.11. The firm had revenue of $14.83 million for the quarter, compared to the consensus estimate of $14.82 million. Semler Scientific had a net margin of 24.08% and a return on equity of 30.15%. Analysts forecast that Semler Scientific, Inc. will post 1.58 earnings per share for the current year.
赛姆勒科学公司(OTCMKTS:SMLR-GET Rating)最近一次发布季度收益报告是在8月2日(星期二)。这家医疗设备供应商公布本季度每股收益(EPS)为0.51美元,高于分析师普遍预期的0.40美元至0.11美元。该公司本季度营收为1483万美元,而市场普遍预期为1482万美元。赛姆勒科学公司的净利润率为24.08%,股本回报率为30.15%。分析师预测,赛姆勒科学公司本年度每股收益将达到1.58美元。

Semler Scientific Profile

塞姆勒科学画像

(Get Rating)

(获取评级)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Semler Science,Inc.提供技术解决方案,以提高美国医疗保健提供者的临床效果和效率。该公司的产品包括QuantaFlo,这是一种四分钟的办公室内血液流动测试,使医疗保健提供者能够使用血流测量作为患者血管状况检查的一部分。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on Semler Scientific (SMLR)
  • Oracle's Short-Term Pain Could Be Your Long-Term Gain
  • Lucid is Looking Like a Clear EV Winner
  • Still Lovin' It: Investors Keep Visiting McDonald's
  • Did FedEx Just Deliver A Buying Opportunity?
  • Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
  • 免费获取StockNews.com关于Semler Science(SMLR)的研究报告
  • 甲骨文的短期痛苦可能是你的长期收益
  • Lucid看起来像是电动汽车的赢家
  • 仍然爱着它:投资者继续光顾麦当劳
  • 联邦快递刚刚提供了一个买入机会吗?
  • 自动区重新进入拉力赛模式,新高在望

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating).

想看看其他对冲基金持有SMLR的情况吗?访问HoldingsChannel.com获取Semler Science,Inc.(OTCMKTS:SMLR-GET Rating)的最新13F文件和内幕交易。

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

接受《塞姆勒科技日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Semler Science及相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发